DOI QR코드

DOI QR Code

Antioxidant, Antihypertensive, and Anti-Inflammatory Activities of Long-Term Ripened Cheddar Cheese Water-Soluble Extract

  • Woojin Ki (Department of Dairy Science, College of Agriculture & Life Sciences, Chungnam National University) ;
  • Gereltuya Renchinkhand (Department of Biology, School of Arts and Sciences, National University of Mongolia) ;
  • Hyoungcheol Bae (Department of Dairy Science, College of Agriculture & Life Sciences, Chungnam National University) ;
  • Myoung Soo Nam (Department of Dairy Science, College of Agriculture & Life Sciences, Chungnam National University)
  • Received : 2024.07.09
  • Accepted : 2024.09.09
  • Published : 2024.11.01

Abstract

During cheese ripening, the proteins in the cheese are broken down, and various functional peptides are produced. This research aimed to investigate the changes in peptides and their physiological activities during the long-term maturation of Cheddar cheese. Young (YC), medium (MC), and 3-year-aged extra-sharp (EC) Cheddar cheeses were extracted with water, and bioactive peptides were identified using ultra performance liquid chromatography-high resolution mass spectrometer. Peptides reported to have antioxidant, angiotensin-converting enzyme (ACE)-inhibitory, and anti-inflammatory effects were identified and evaluated in the extracts. MC and EC showed stronger antioxidant activity than YC. The 2,2'-azino-bis-(3-ethylbenzothiazoline-6-sulfonic) acid inhibition rates of MC and EC were similar, but EC exhibited a higher 2,2-diphenyl-1-picrylhydrazyl inhibition rate. The antihypertensive effect was found to increase owing to the appearance of peptides with ACE-inhibitory activity in MC and EC. Quantitative real time polymerase chain reaction and immunoblot were run to evaluate the anti-inflammatory effects. YC did not show anti-inflammatory activity, but MC and EC were shown to effectively inhibit inflammatory mRNA expression. The immunoblot results showed that EC did not inhibit IκBα phosphorylation, but had an inhibitory effect at the mRNA expression level. Overall, the peptides contained in aged Cheddar cheese were shown to have excellent antioxidant, anti-inflammatory, and antihypertensive activities, and long-term ripening appeared to have a positive effect on these activities. This is presumed to have affected not only the already identified peptides but also unknown peptides; therefore, it is expected that the discovery of bioactive peptides will be possible through additional research.

Keywords

Introduction

In bovine milk, functional proteins, such as lactoferrin, immunoglobulins, and growth factors secreted from the mammary gland exist in an active state and exert biological activity. Milk proteins are superior in nutritional value alone, but they are attracting more attention for their physiological roles and are currently recognized as sources of various biologically active peptides (Pihlanto, 2006).

Bioactive peptides are isolated portions of proteins that have beneficial effects on various physiological functions and physical and mental health. These peptides have positive effects on antioxidant, antithrombotic, antihypertensive, antibacterial, and immunomodulatory properties, and have received considerable attention for their potential bioactivities (Lin et al., 2022). Recent studies have suggested that bioactive peptides may have positive effects on diseases such as obesity and hyperlipidemia (Song et al., 2022).

Cheese is a widely consumed dairy product that is highly regarded for its unique flavor, pleasing texture, and rich nutrients. It is a notable reservoir of proteins, fats, vitamins, and minerals. Cheese is high in protein and is a source of various milk derived peptides, depending on the diversity of proteolytic systems and the intensity of proteolysis during ripening (Park et al., 2007). Enzymes present in milk, derived from rennet or secreted by microorganisms, can break down casein and produce bioactive peptides (Pihlanto, 2006). The degradation of milk proteins is affected by several factors like pH, plasmin, chymosin, enzymes secreted by microorganisms, salt, storage period and temperature, and humidity (Park and Jin, 1998).

The physiologically active peptide content of cheese is enhanced by the specific probiotic strains used in the cheese manufacturing process and ripening. Studies on Cheddar cheese have shown that the use of Lactobacillus casei 300 results in peptides having antihypertensive activity (Giosuè et al., 2022). Moreover, it has been demonstrated that the use of specific proteases in cheese production further increases the appearance of bioactive peptides. Therefore, even in the same type of cheese, the type, amount, and function of bioactive peptides are likely to vary depending on the degree of ripening.

Cheddar cheese is a hard, mostly orange-colored, natural cheese. It is known to have originated from the English town of Cheddar in Somerset. Cheddar is the most popular cheese type in the UK, and accounts for 51% of the annual cheese market. In the United States, cheddar is the 2nd most consumed cheese after mozzarella, and the average annual consumption per person is 10 pounds (4.5 kg). Likewise, cheddar is a type of cheese that is easily accessible and loved in many countries.

Therefore, research on Cheddar cheese peptides according to ripening stage is expected to reveal changes in composition and functionality at each stage, and based on this, its value as a fermented food will be reaffirmed. Our study focused on evaluating the anti-inflammatory effect, antioxidant, and antihypertensive functions of Cheddar cheese, a commonly consumed cheese, at different ripening stages.

Materials and Methods

Preparation of Cheddar water-soluble extracts

In this study, extra-sharp (3-year-ripened), medium (6-mon-ripened), and young (early stages of ripening, 1-mon-ripened) Cheddar cheeses manufactured by the Animal Resources Research Center of Chungnam National University, Korea, were used as samples and categorized into the extra-sharp Cheddar cheese water-soluble extract (EC), medium Cheddar cheese water-soluble extract (MC), and young Cheddar cheese water-soluble extract (YC) groups, respectively. Each cheese sample was finely ground, and 20 g was placed into 180 mL of distilled water (DW) and extracted with an ultrasonic extractor (1 h, 40℃). Each water-soluble extract (WSE) was cooled and centrifuged (Supra R17, Hanil Science, Ansan, Korea) at 6,000×g (20 min, 4℃) to remove the fat layer, and the WSEs was taken and filtered with Whatman No. 2 (Whatman, Maidstone, UK). Finally, the WSE was lyophilized and kept at −20℃ until further analysis.

Quantification of water-soluble nitrogen in Cheddar

To evaluate the ripeness of Cheddar cheese, the nitrogen fraction quantification method (Bütikofer et al., 1993) was applied to measure the change in water-soluble nitrogen (WSN).

Each cheese was finely grinded, mixed in a ratio of 5 g of cheese to 20 mL of sterilized DW, and homogenized at 20,000 rpm for 5 min with a homogenizer (ULTRA TURRAX T25, IKA, Wilmington, NC, USA). It was centrifuged at 4°C, 3,000×g for 30 min to remove the fat, and the supernatant was filtered with by Whatman No. 2 (Whatman).

Subsequently, following Hull's method (Hull, 1947), 2.5 mL of the filtrate was combined with 5.0 mL of reagent A (12% trichloroacetic acid and 0.5 mL of DW). The mixture was left at room temperature for 20 min and then filtered with Whatman No. 42 (Whatman) to obtain filtrate. Then, 2.5 mL of filtrate was taken, 5.0 mL of Reagent B (75 g of sodium carbonate and 10 g of sodium hexametaphosphate dissolved in 500 mL of DW) and 1.5 mL of Reagent C [50 mL of folin & Ciocalteu′s phenol reagent (Sigma-Aldrich, St. Louis, MO, USA) dissolved in 100 mL of DW] and reacted for 30 min in a 30℃ water bath. After the completion of color development, the WSN content was measured at 570 nm using a spectrophotometer (UV-1700, Shimadzu, Kyoto, Japan), and their quantification was calculated by a linear regression formula with tyrosine as the standard.

Protein content and pH of the Cheddar water-soluble extracts

Protein quantification and pH measurements were performed to confirm the protein content and characteristics of Cheddar WSEs used in this study. The protein content of Cheddar WSEs were measured using the protein quantification method (Bradford, 1976). Lyophilized WSE diluted in sterilized DW at a concentration of 10 mg/mL was used as a measurement sample. Protein Assay Dye Reagent Concentrate (Bio-Rad Laboratories, Hercules, CA, USA) was diluted with DW in a 1:4 ratio and used as Bradford dye reagent. Measurements were made by placing 10 μL of sample solution and 200 μL of dye reagent in each well of a 96-well plate and measuring absorbance at 595 nm with microplate reader. Afterwards, bovine serum albumin (BSA, Bio-Rad Laboratories) was used as a standard substance to quantify the protein content in the sample.

The pH measurement was performed by mixing YC, MC, and EC lyophilized substances with DW at a concentration of 2% (w/v) and measuring at 25°C with a pH meter (S-20K, Mettler-Toledo, Columbus, OH, USA).

Bioactive peptide profiles of Cheddar water-soluble extracts

Cheddar WSE was dissolved in DW at a concentration of 100 ppm, filtered with a 0.2 μm syringe filter (HM, Anseong, Korea), and used for ultra performance liquid chromatography-high resolution mass spectrometer (UHPLC-HRMS) analysis. HRMS (TripleTOF 5600 plus, SCIEX, Framingham, MA, USA) detector and UHPLC system (1290 Infinity II, SCIEX) were used for analysis. Chromatography was performed using a 2-solvent gradient elution [solvent A: 0.1% formic acid in deionized water (v/v), solvent B: 0.1% formic acid in acetonitrile (v/v)]. The mass spectrometer was operated in (+) ion mode. Data were analyzed using AB SCIEX software. Information on milk-derived peptides was collected from the Milk Bioactive Peptide Database (https://mbpdb.nws.oregonstate.edu/) and analyzed.

Antioxidant activity evaluation by 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic) acid

The 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic) acid (ABTS) radical scavenging was measured using a decolorization assay (Re et al., 1999). The ABTS radical solution was prepared by reacting the ABTS (Sigma-Aldrich) solution (7 mM) with potassium persulfate solution (2.4 mM), keeping the mixture in the dark at 25℃ for 12–16 h before use. The ABTS radical solution was diluted with DW to an absorbance of 0.7 (±0.02) at 734 nm. A 50 μL sample was mixed with 950 μL of diluted ABTS•+ solution, and the absorbance (734 nm) was measured after 10 min. L-ascorbic acid was used as a positive control, and the rate of inhibition was calculated as follows:

Inhibition rate (%) = [{1 − (Sample − Sample blank) / (Control − Control blank)} × 100]       (1)

Antioxidant activity evaluation by 2,2-diphenyl-1-picrylhydrazyl

Inhibition of 2,2-diphenyl-1-picrylhydrazyl (DPPH) by cheddar cheese was evaluated using a modified free radical method (Brand-Williams et al., 1995). The sample diluted in 20 μL of DW was dispensed into a 96-well plate with 180 μL of freshly prepared 0.2 mM DPPH (Sigma-Aldrich) methanol solution. After reaction in the dark (15 min), the decrease in absorbance at 517 nm was measured using a microplate reader (Thermo Fisher Scientific, Waltham, MA, USA). In the same way, blank values were determined using DW. Scavenging rate was expressed as follows:

Scavenging rate (%) = [1 − (A / A0)] × 100,       (2)

Where A is the absorbance of the sample and A0 is the absorbance of the blank.

Angiotensin-converting enzyme-inhibitory activity

Angiotensin-converting enzyme (ACE)-inhibitory activity was measured using an in vitro spectrophotometric assay (Cushman and Cheung, 1971) with some modifications. Rabbit lung acetone powder (Sigma-Aldrich) was mixed at 1:10 with 0.1 M sodium borate buffer containing 0.3 M NaCl and extracted by shaking at 4°C for 24 h. After centrifugation at 15,000×g for 30 min, the supernatant was collected and used as the ACE enzyme. As a substrate, hippuryl-histidyl-leucine (HHL, Sigma-Aldrich) was diluted to a concentration of 5 mM in 0.1 M sodium borate buffer containing 0.3 M NaCl. Captopril (Sigma-Aldrich) was used as the positive control. Then, 100 μL of 0.1 M sodium borate buffer and 50 μL of ACE enzyme were added to 50 μL of the sample, which was preincubated at 37°C for 5 min, after which 50 μL of substrate was added and reacted at 37°C for 30 min. After the reaction, 300 μL of 0.1 N HCl was added to stop the reaction, followed by adding 1 mL of ethyl acetate, stirring for 15 s, and centrifugation at 4°C and 960×g for 5 min. The supernatant was completely dried in a vacuum concentrator (Hanil, Daejeon, Korea), 1 mL of DW was added, and the absorbance was measured at 228 nm. A sample blank was prepared by stopping the reaction with 300 μL of 0.1 N HCl before adding the ACE enzyme. The rate of inhibition was calculated as described in the ABTS assay.

Cell culture

RAW 264.7 cells, purchased from the Korean Cell Line Bank, were used in the experiments. The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, WELGENE, Gyeongsan, Korea) supplemented with 10% (v/v) of fetal bovine serum (FBS, WELGENE), and 1% (v/v) of penicillin and streptomycin (WELGENE). The cells were cultured under conditions at 37℃ and 5% CO2.

Cell viability assay

To determine the effect of Cheddar WSE on cell activity, a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay was performed. RAW 264.7 cells were seeded in a 96-well plate at 3,000 cells/well and cultured for 24 h. The samples were treated at each concentration in each well and cultured for another 24 h. Subsequently, MTS solution (Promega, Madison, WI, USA) was added to each well, and the absorbance was measured at 490 nm with microplate reader (EMax Plus, Molecular Devices, San Jose, CA, USA). The relative toxicity was measured by expressing the activity of cells treated with the sample as a percentage of the untreated control group.

Quantitative real time polymerase chain reaction

RAW 264.7 cells were seeded on a 6-well plate at 1.5×105 cells/well and cultured for 24 h. The cultures were then replaced with culture medium treated with YC, MC, or EC WSE at a concentration of 100 μg/mL, or with untreated culture medium, and cultured for 24 h. Subsequently, each well was treated with 1 μg/mL lipopolysaccharide (LPS) and cultured for 6 h. After complete removal of the culture medium, the cells were washed with PBS, lysed with 1 mL of Ribo Ex (Gene All, Seoul, Korea), and RNA was extracted using a Hybrid-R RNA purification kit (Gene All). To synthesize cDNA, RNA was quantified using a Nabi UV/Vis Nano Spectrophotometer (Micro Digital, Seongnam, Korea). Then, 1 μL of random hexamer (100 pmol/μL) and 1 μL of dNTP mix (10 mM) were added to 1 μg of total RNA, and the total volume was adjusted to 10 μL using DEPC-treated water. The mixture was reacted at 65℃ for 5 min and immediately cooled on ice. Subsequently, 1 μL of M-MLV reverse transcriptase (Promega), 4 μL of 5X M-MLV RT reaction buffer (Promega), 1 μL of RNase inhibitor (Enzynomics, Daejeon, Korea), and 4 μL of DEPC-treated water were added. After incubating at room temperature for 10 min, cDNA was synthesized by reacting at 50℃ for 1 h.

The mRNA expression levels of inflammatory cytokines were compared using quantitative real time polymerase chain reaction (qRT-PCR). After diluting 2 μL of cDNA to 1/10, qRT-PCR was performed using 5 μL of nuclease-free water, 10 μL of 2X Prime Q-master Mix (GenET BIO, Nonsan, Korea), 10 pmol/μL forward primers, and 10 pmol/μL reverse primers. Using the AriaMx (Agilent, Santa Clara, CA, USA), 40 cycles of denaturation at 95℃ for 20 s, annealing at 58℃ for 20 s, and elongation at 72℃ for 20 s were performed. The nucleotide sequences of the primers used in the experiment were as follows:

IL-1β: (F) 5'-AGG TCA AAG GTT TGG AAG CA-3', (R) 5'-TGA AGC AGC TAT GGC AAC TG-3'; IL-6: (F) 5'- GTC CTT CAG AGA GAT ACA GAA ACT-3', (R) 5'-AGC TTA TCT GTT AGG AGA GCA TTG-3'; TNF-α: (F) 5'-AGG GTC TGG GCC ATA GAA CT-3', (R) 5'-CCA CCA CGC TCT TCT GTC TAC-3'; iNOS: (F) 5'-CAG CTG GGC TGT ACA AAC CTT-3', (R) 5'-CAT TGG AAG TGA AGC GTT TCG-3'; GAPDH: (F) 5'-CCA TGG AGA AGG CTG GGG-3', (R) 5'-CAA AGT TGT CAT GGA TGA CC-3'.

Immunoblotting

RAW 264.7 cells were seeded on a 6-well plate at 1.5×105 cells/well and cultured for 24 h. The culture medium was removed, and medium treated with or without YC, MC, and EC WSE at a concentration of 100 μg/mL was dispensed and cultured for 24 h. LPS was treated at a concentration of 1 μg/mL for 30 min. Then, each well was then immediately washed with ice-cold PBS, and lysates were extracted using lysis buffer [10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 10% (v/v) glycerol, and 1% (v/v) Triton X-100]. Lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for 1 h and transferred to a nitrocellulose membrane. Next, blocking was performed for 1 h with 5% (w/v) skim milk dissolved in PBST. The membrane was treated with antibodies against p-IκBα (1:1,000; Cell Signaling Technology, Danvers, MA, USA), IκBα (1:1,000; Cell Signaling Technology), and GAPDH (1:2,000; Cell Signaling Technology) for 12 h. After washing the membrane with PBST, the membrane was incubated with horseradish-conjugated secondary antibodies (Cell Signaling Technology) for 1 h, 25℃. Protein signals were detected using a Luminograph I (ATTO, Tokyo, Japan) after reacting the membrane with a SuperSignal (Thermo Fisher Scientific). The protein bands were quantified using ImageJ (NIH, Bethesda, MD, USA).

Statistical analysis

All experiments were repeated in triplicates, and data were presented as mean±SE. The significance of the experimental group was tested for the control group using Student’s t-test and was judged to be statistically significant when the p-value was less than 0.05.

Results and Discussion

Bioactive peptide profiles of Cheddar water-soluble extracts

Using the UHPLC-HRMS technique, we analyzed the bioactive peptide composition of the YC, MC, and EC samples based on the milk-derived functional peptide database. The UHPLC-HRMS analysis result of the YC, MC, and EC samples are shown in Figs. 1, 2, and 3, respectively. The peptides matching the database comparison results and the known physiological activities of each peptide are shown in Tables 1, 2, and 3. For YC, which was in the early stages of ripening, two peptides (IQP and LQP) with ACE-inhibitory effects were identified by bioactive peptide comparison. In the case of MC(aged for 6 mon), LPP, which has an ACE-inhibiting effect, and IPP and VPP, which are known to have anti-inflammatory, antioxidant, and ACE-inhibiting effects, were discovered. In EC (aged for 3 years), various peptides were identified over the long protein degradation period, and several additional peptides (YKVPQL, LPP, VP, IR, LL, and VSP) were detected. Based on these results, EC, aged for 3 years, contained the most bioactive peptides were found among the three experimental groups. Thus, the results confirm that various bioactive peptides appear during long-term ripening.

CSSPBQ_2024_v44n6_1373_6_f0001.png 이미지

Fig. 1. UHPLC-HRMS analysis of young Cheddar cheese water soluble extract. The concentration of the sample was 100 ppm, and the sample injection volume was 20 μL. Results display the identified peptides against the peptide data along with the total peaks observed upon detection. Among these, the peptides detected when the threshold was set to 1,000 were collected as results. UHPLC, ultra performance liquid chromatography; HRMS, high resolution mass spectrometer.

CSSPBQ_2024_v44n6_1373_6_f0001.png 이미지

Fig. 2. UHPLC-HRMS analysis of medium Cheddar cheese water soluble extract. The concentration of the sample was 100 ppm, and the sample injection volume was 20 μL. Results display the identified peptides against the peptide data along with the total peaks observed upon detection. Among these, the peptides detected when the threshold was set to 1,000 were collected as results. UHPLC, ultra performance liquid chromatography; HRMS, high resolution mass spectrometer.

CSSPBQ_2024_v44n6_1373_7_f0002.png 이미지

Fig. 3. UHPLC-HRMS analysis of extra-sharp Cheddar cheese water soluble extract. The concentration of the sample was 100 ppm, and the sample injection volume was 20 μL. Results display the identified peptides against the peptide data along with the total peaks observed upon detection. Among these, the peptides detected when the threshold was set to 1,000 were collected as results. UHPLC, ultra performance liquid chromatography; HRMS, high resolution mass spectrometer.

Table 1. Identification of functional peptides in young Cheddar cheese WSE

CSSPBQ_2024_v44n6_1373_8_t0001.png 이미지

WSE, water-soluble extract; ACE, angiotensin-converting enzyme.

Table 2. Identification of functional peptides in medium Cheddar cheese WSE

CSSPBQ_2024_v44n6_1373_8_t0002.png 이미지

WSE, water-soluble extract; ACE, angiotensin-converting enzyme.

Table 3. Identification of functional peptides in extra-sharp Cheddar cheese WSE

CSSPBQ_2024_v44n6_1373_8_t0003.png 이미지

WSE, water-soluble extract; ACE, angiotensin-converting enzyme.

Changes in water-soluble nitrogen content with long-term ripening of Cheddar

The WSN content of Cheddar cheese gradually increased as the ripening period progressed (Table 4). The increase in WSN of cheese during the ripening period is generally caused by casein degradation and varies depending on the rennet used in cheese production or the protease secreted by the starter (Galán et al., 2008). In addition, it has been confirmed that protease produced from the cheese starter causes continuous protein degradation (Sallami et al., 2004). Therefore, the increase in WSN compounds is used as an indicator of ripening progress. In addition, the results of this study confirmed that WSN increases as the ripening period progresses from YC to MC and from MC to EC and is proportional to the degree of ripening.

Table 4. Changes in water-soluble nitrogen content during ripening of Cheddar cheese

CSSPBQ_2024_v44n6_1373_9_t0001.png 이미지

1) n=3

Protein content and pH changes in Cheddar water-soluble extracts

The protein content and pH value of each Cheddar cheese WSE are shown in Table 5. Each sample was compared after completely dissolving the freeze-dried powder in DW at a certain concentration. As a result, the protein content in YC was 20.01 mg BSA/g DM, and MC and EC were slightly reduced to 19.66 mg BSA/g DM and 16.63 mg BSA/g DM, respectively.

Table 5. Protein content and pH of Cheddar cheese WSE

CSSPBQ_2024_v44n6_1373_9_t0002.png 이미지

1) n=3.

WSE, water-soluble extract; BSA, bovine serum albumin; DM, dry matter; DW, distilled water; YC, young Cheddar cheese water-soluble extract; MC, medium Cheddar cheese water-soluble extract; EC, extra-sharp Cheddar cheese water-soluble extract.

The pH value of Cheddar cheese WSE showed no difference from YC (5.69) in MC (5.71), but decreased to 5.57 in EC.

2,2′-Azino-bis-(3-ethylbenzothiazoline-6-sulfonic) acid radical inhibition of Cheddar water-soluble extracts

The ABTS radical inhibition rate (%) was compared by treating each sample at the same concentration, as shown in Fig. 4. YC exhibited a scavenging activity of 25.99±0.18%. On the other hand, MC and EC, which underwent longer ripening, demonstrated significantly higher scavenging activities of 57.90±0.54% and 56.08±0.26%, respectively.

CSSPBQ_2024_v44n6_1373_10_f0001.png 이미지

Fig. 4. ABTS radical scavenging activity of Cheddar cheese water soluble extract. The concentration of each sample was the same at 5 mg to compare antioxidant activity on ABTS, and L-ascorbic acid was used as a positive control. Results are expressed as the mean±SEM (n=3). *** p<0.001 (two-sided t-test, versus young Cheddar cheese water soluble extract). ASC, L-ascorbic acid; YC, young Cheddar cheese water-soluble extract; MC, medium Cheddar cheese water-soluble extract; EC, extra-sharp Cheddar cheese water-soluble extract; ABTS, 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic) acid.

2,2-Diphenyl-1-picrylhydrazyl radical scavenging activity of Cheddar water-soluble extracts

The DPPH radical scavenging ability of Cheddar cheese tended to increase gradually with the maturation period, as shown in Fig. 5. At the beginning of ripening (YC), the activity was 36.77±0.14%; in the middle (MC), it was 43.73±0.06%; and after 3 years (EC), it was 62.00±0.10%. Similar to the ABTS assay results, the DPPH radical scavenging ability was higher in MC and EC compared to YC. However, unlike the ABTS assay, EC showed the highest radical scavenging ability, demonstrating excellent DPPH scavenging activity. DPPH inhibition rate, and its activity gradually increased with the ripening period. These results are believed to be related to the presence of peptides (IPP and VPP) with antioxidant activity, as previously confirmed by the Bioactive Peptide Profile. In addition, it was confirmed that Cheddar cheese has excellent antioxidant ability through ripening.

CSSPBQ_2024_v44n6_1373_10_f0002.png 이미지

Fig. 5. DPPH radical scavenging activity of Cheddar cheese water soluble extract. The concentration of each sample was the same at 10 mg to compare antioxidant activity on DPPH, and L-ascorbic acid was used as a positive control. Results are expressed as the mean±SEM (n=3). *** p<0.001 (two-sided t-test, versus young Cheddar cheese water soluble extract). ASC, L-ascorbic acid; YC, young Cheddar cheese water-soluble extract; MC, medium Cheddar cheese water-soluble extract; EC, extra-sharp Cheddar cheese water-soluble extract; DPPH, 2,2-diphenyl-1-picrylhydrazyl.

Angiotensin-converting enzyme-inhibitory activity of Cheddar water-soluble extracts

The antihypertensive properties of Cheddar WSEs were estimated based on their inhibitory effects on ACE activity. This enzyme functions to convert angiotensin I to angiotensin II, which produces a powerful vasoconstriction effect and increases blood pressure by inactivating bradykinin, which acts as a vasodilator (Pihlanto-Leppälä et al., 1998). The improved ACE inhibitory activity with ripening suggests that sufficiently mature cheese is a good functional food with antihypertensive activity.

Regardless of the differences in ripening time, the ACE inhibition rate increased in all three experimental groups in this study (Table 6). YC showed relatively low ACE-inhibitory activity (47.02%) because it is a raw cheese in the early stages of ripening after production. In contrast, fully aged MC and EC showed very high ACE-inhibitory activities, which was associated with the appearance of various previously analyzed functional peptides. MC showed a high ACE-inhibitory activity of 80.35%, and while further aging did not increase this activity, EC still exhibited a high ACE-inhibitory activity of 75.04%.

Table 6. ACE inhibitory effect of Cheddar cheese WSE according to ripening period

CSSPBQ_2024_v44n6_1373_11_t0001.png 이미지

1) n=3.

ACE, angiotensin-converting enzyme; WSE, water-soluble extract; YC, young Cheddar cheese water-soluble extract; MC, medium Cheddar cheese water-soluble extract; EC, extra-sharp Cheddar cheese water-soluble extract.

Previous studies on peptides from Cheddar cheese (Ong et al., 2007) reported that the ability to inhibit ACE depends on the degree of protein degradation, with inhibition peaking and then gradually decreasing as a result of extensive protein degradation. The present study showed a similar trend. However, the results revealed that the ACE-inhibitory activity did not significantly decrease after the middle period of ripening (MC) but remained strong even after 3 years (EC).

Effects of Cheddar water-soluble extracts on RAW 264.7 cells

RAW 264.7 cells were treated with YC, MC, and EC, and the MTS assay was performed to evaluate the survival rate at various concentrations. Concentrations ranged from 500 μg/mL to 50 μg/mL, and each sample was added and incubated for 24 h. Cytotoxicity was assessed by comparing the treated samples with the untreated control cells. Overall, cell activity in the treatment groups was higher than that in the control group, with YC showing the highest cell activity (Fig. 6).

Fig. 6. Effect of Cheddar cheese water soluble extract on cell viability. RAW 264.7 cells were treated with indicated concentrations of YC, MC, EC for 24 h. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay. Results are expressed as the mean±SEM (n=3). * p<0.05 (two-sided t-test, versus control). ■, young Cheddar cheese watersoluble extract (YC); ●, medium Cheddar cheese water-soluble extract (MC); ▲, extra-sharp Cheddar cheese water-soluble extract (EC).

The cell activity under YC treatment was 152.7±3.8% at 500 μg/mL, followed by 138.1±2.2% at 250 μg/mL, 115.3±0.9% at 100 μg/mL, and 102.9±1.5% at 50 μg/mL. However, visual observation of the cells revealed no significant differences from the control cells, indicating that the treatments affected cell activity but not cell number. Therefore, for subsequent experiments, the maximum concentration was set to 100 μg/mL to better assess the effects of YC, MC, and EC on cell activity.

Effects on inflammatory mRNA expression

Phosphorylation of IκBα promotes NF-κB signaling, which promotes the expression of pro-inflammatory cytokines like IL-6 and IL-1β and inflammatory cytokines like TNF-α and iNOS (Aderem and Ulevitch, 2000). To evaluate the effect of Cheddar WSE treatment on the inflammatory response induced by LPS in RAW 264.7 cells, mRNA expression levels were calculated.

The expression of inflammatory mRNA tended to decrease with the ripening period (Fig. 7). Specifically, the IL-6 expression level in EC decreased to 9.88%, IL-1β expression to 35.97%, TNF-α expression to 65.29%, and iNOS expression to 72.20%. Consistent with earlier findings in this study, the emergence of anti-inflammatory peptides during Cheddar cheese ripening appears to contribute to the observed anti-inflammatory effects. Accordingly, inflammatory mRNA expression decreased, and the effect became more significant as the ripening period progressed.

Fig. 7. Effect of Cheddar cheese WSE on inflammatory mRNA expression. RAW 264.7 cells were pretreated with Cheddar cheese WSE at concentration of 100 μg/mL for 24 h and then incubated with LPS (1 μg/mL) for 6 h. qRT-PCR was performed to analyze the mRNA expression of the IL-1β, IL-6, and TNF-α, and iNOS. Results are expressed as the mean±SEM (n=3). * p<0.05, *** p<0.001 (two-sided t-test, versus control). IL-1β, interleukin-1β; LPS, lipopolysaccharide; YC, young Cheddar cheese water-soluble extract; MC, medium Cheddar cheese water-soluble extract; EC, extra-sharp Cheddar cheese water-soluble extract; IL-6, interleukin-6; TNF-α, tumour necrosis factor-α; iNOS, inducible nitric oxide synthase; WSE, water-soluble extract; qRT-PCR, quantitative real time polymerase chain reaction.

Inhibitory effect on IκBα phosphorylation

We found that the WSE of sufficiently aged Cheddar effectively inhibited inflammatory signaling in RAW 264.7 cells. Based on these results, it was assumed that Cheddar WSEs would inhibit the phosphorylation levels of IκBα, which induces an inflammatory response. To evaluate the effect of Cheddar WSEs on the inflammatory response, RAW 264.7 cells were treated at a concentration of 100 μg/mL and then treated with LPS to induce an inflammatory response. Next, immunoblot analysis was performed to confirm the effect on the signaling action of NF-κB, which mainly regulates the inflammatory response (Fig. 8). The results revealed that YC treatment induced IκBα phosphorylation 24% more strongly than treatment with LPS alone. In contrast, MC inhibited the IκBα phosphorylation induced by LPS treatment by 74%, indicating a strong anti-inflammatory effect. However, under EC treatment, in contrast to MC, IκBα phosphorylation increased by 13%. From these results, it appears that MC suppressed the inflammatory response of macrophages by inhibiting the phosphorylation of IκBα, but no significant inhibitory activity was observed in EC. Evaluation of the anti-inflammatory activity of Cheddar WSEs showed no anti-inflammatory activity at the beginning of ripening (YC); however, the peptides produced during the ripening process effectively suppressed the inflammatory response. Although this inhibition did not inhibit phosphorylation of IκBα, it showed that an inhibitory effect occurred at the level of inflammatory mRNA expression. The underlying mechanism needs to be elucidated in future studies.

Fig. 8. Inhibitory effect of IκBα phosphorylation of Cheddar cheese WSE. RAW 264.7 cells were cultured by adding 100 μg/mL of cheddar cheese extracts of different degrees of ripeness for 24 hours, and then stimulated with LPS (1 μg/mL) for 30 minutes. Immunoblotting was performed with proteins extracted from these cells. The numbers at the bottom of the p-IκBα band indicate the relative intensity of the p-IκBα band. Quantitative analysis was performed using densitometry and normalisation to IκBα, with GAPDH serving as the loading control. YC, young Cheddar cheese water-soluble extract; MC, medium Cheddar cheese water-soluble extract; EC, extra-sharp Cheddar cheese water-soluble extract; LPS, lipopolysaccharide; IκBα, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; WSE, water-soluble extract.​​​​​​​

Conclusion

This study was conducted to investigate the changes in peptides and their physiological activities during the long-term aging of cheddar cheese. WSE was prepared for each aging period, and the content of bioactive peptides, antioxidant activity, antihypertensive activity, and anti-inflammatory effects were evaluated. The results show that various peptides present in aged cheddar cheese have excellent antioxidant, anti-inflammatory, and antihypertensive activities, and that long-term aging positively affects these activities. It is presumed that this was influenced not only by previously identified peptides but also by unknown peptides. However, this study did not involve the isolation of peptides or the measurement of their content. Additionally, bioactive peptides that were not discovered could not be confirmed. Therefore, research on the isolation of peptides and their individual activities should be conducted in the future, and biological experiments should be carried out to provide evidence of their practical activities.

Conflicts of Interest

The authors declare no potential conflicts of interest.

Acknowledgements

This study was supported by the Animal Resources Research Center of Chungnam National University for the preparation and ripening of cheese samples.

Author Contributions

Conceptualization: Nam MS. Data curation: Ki W, Nam MS. Formal analysis: Ki W, Renchinkhand G, Bae H, Nam MS. Methodology: Ki W, Renchinkhand G, Bae H, Nam MS. Software: Ki W. Validation: Nam MS. Investigation: Ki W, Renchinkhand G, Bae H, Nam MS. Writing - original draft: Ki W. Writing - review & editing: Ki W, Renchinkhand G, Bae H, Nam MS.

Ethics Approval

This article does not require IRB/IACUC approval because there are no human and animal participants.

References

  1. Adams C, Sawh F, Green-Johnson JM, Jones Taggart H, Strap JL. 2020. Characterization of casein-derived peptide bioactivity: Differential effects on angiotensin-converting enzyme inhibition and cytokine and nitric oxide production. J Dairy Sci 103:5805-5815.
  2. Aderem A, Ulevitch RJ. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406:782-787.
  3. Aihara K, Osaka M, Yoshida M. 2014. Oral administration of the milk casein-derived tripeptide Val-Pro-Pro attenuates high-fat diet-induced adipose tissue inflammation in mice. Br J Nutr 112:513-519.
  4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
  5. Brand-Williams W, Cuvelier ME, Berset C. 1995. Use of a free radical method to evaluate antioxidant activity. LWT-Food Sci Technol 28:25-30.
  6. Butikofer M, Ruegg M, Ardo Y. 1993. Determination of nitrogen fractions in cheese: Evaluation of a collaborative study. LWT-Food Sci Technol 26:271-275.
  7. Chakrabarti S, Liao W, Davidge ST, Wu J. 2017. Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) differentially modulate angiotensin II effects on vascular smooth muscle cells. J Funct Foods 30:151-158.
  8. Cushman DW, Cheung HS. 1971. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 20:1637-1648.
  9. Galan E, Prados F, Pino A, Tejada L, Fernandez-Salguero J. 2008. Influence of different amounts of vegetable coagulant from cardoon Cynara cardunculus and calf rennet on the proteolysis and sensory characteristics of cheeses made with sheep milk. Int Dairy J 18:93-98.
  10. Giosue C, D'Agostino F, Maniaci G, Avellone G, Sciortino M, De Caro V, Bonanno A, Ponte M, Alabiso M, Grigoli AD. 2022. Persistent organic pollutants and fatty acid profile in a typical cheese from extensive farms: First assessment of human exposure by dietary intake. Animals 12:3476.
  11. Hull ME. 1947. Studies on milk proteins. II. Colorimetric determination of the partial hydrolysis of the proteins in milk. J Dairy Sci 30:881-884.
  12. Jing P, Qian B, He Y, Zhao X, Zhang J, Zhao D, Lv Y, Deng Y. 2014. Screening milk-derived antihypertensive peptides using quantitative structure activity relationship (QSAR) modelling and in vitro/in vivo studies on their bioactivity. Int Dairy J 35:95-101.
  13. Lin P, Di H, Li Z, Wang Y, Zhou W, Huang S, Zhang C, Li H, Zhang F, Sun B. 2022. Light irradiation maintains the sensory quality, health-promoting phytochemicals, and antioxidant capacity of post-harvest baby mustard. J Food Sci 87:112-123.
  14. Maeno M, Yamamoto N, Takano T. 1996. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci 79:1316-1321.
  15. Murakami M, Tonouchi H, Takahashi R, Kitazawa H, Kawai Y, Negishi H, Saito T. 2004. Structural analysis of a new antihypertensive peptide (β-lactosin B) isolated from a commercial whey product. J Dairy Sci 87:1967-1974.
  16. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. 1995. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78:777-783.
  17. Norris R, Poyarkov A, O'Keeffe MB, FitzGerald RJ. 2014. Characterisation of the hydrolytic specificity of Aspergillus niger derived prolyl endoproteinase on bovine β-casein and determination of ACE inhibitory activity. Food Chem 156:29-36.
  18. Ong L, Henriksson A, Shah NP. 2007. Angiotensin converting enzyme-inhibitory activity in cheddar cheeses made with the addition of probiotic Lactobacillus casei sp. Le Lait 87:149-165.
  19. Pan D, Cao J, Guo H, Zhao B. 2012. Studies on purification and the molecular mechanism of a novel ACE inhibitory peptide from whey protein hydrolysate. Food Chem 130:121-126.
  20. Park YW, Jin YK. 1998. Proteolytic patterns of Caciotta and Monterey Jack hard goat milk cheeses as evaluated by SDS-PAGE and densitometric analyses. Small Rumin Res 28:263-272.
  21. Park YW, Juarez M, Ramos M, Haenlein GFW. 2007. Physico-chemical characteristics of goat and sheep milk. Small Rumin Res 68:88-113.
  22. Pihlanto A. 2006. Antioxidative peptides derived from milk proteins. Int Dairy J 16:1306-1314.
  23. Pihlanto-Leppala A, Rokka T, Korhonen H. 1998. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 8:325-331.
  24. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. 1999. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231-1237.
  25. Sallami L, Kheadr EE, Fliss I, Vuillemard JC. 2004. Impact of autolytic, proteolytic, and nisin-producing adjunct cultures on biochemical and textural properties of Cheddar cheese. J Dairy Sci 87:1585-1594.
  26. Song Y, Cai Q, Wang S, Li L, Wang Y, Zou S, Xiang G, Wei Y. 2022. The ameliorative effect and mechanisms of Ruditapes philippinarum bioactive peptides on obesity and hyperlipidemia induced by a high-fat diet in mice. Nutrients 14:5066.
  27. Tonouchi H, Suzuki M, Uchida M, Oda M. 2008. Antihypertensive effect of an angiotensin converting enzyme inhibitory peptide from enzyme modified cheese. J Dairy Res 75:284-290.
  28. Weimann C, Meisel H, Erhardt G. 2009. Short communication: Bovine κ-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides. J Dairy Sci 92:1885-1888.